Epoprostenol for Treatment of Pulmonary Hypertension in Patients With Systemic Lupus Erythematosus
- 1 January 2000
- Vol. 117 (1) , 14-18
- https://doi.org/10.1378/chest.117.1.14
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Pulmonary hypertension in connective tissue diseaseRheumatology International, 1991
- Pleuro-pulmonary Manifestations of Systemic Lupus Erythematosus: Clinical Features of its SubgroupsChest, 1985
- Cardiovascular Manifestations in Systemic Lupus Erythematosus. Prospective Study of 100 PatientsAngiology, 1985
- Pulmonary Hypertension and Systemic Lupus ErythematosusArchives of internal medicine (1960), 1980
- Severe Pulmonary Vascular Disease in Systemic Lupus ErythematosusSouthern Medical Journal, 1979
- Pulmonary vascular changes in sclerodermaThe American Journal of Medicine, 1978
- Primary Pulmonary HypertensionCirculation, 1970
- The Pathology of Hypertensive Pulmonary Vascular DiseaseCirculation, 1958